These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

911 related items for PubMed ID: 19329573

  • 1. Directed differentiation of pluripotent stem cells: from developmental biology to therapeutic applications.
    Irion S, Nostro MC, Kattman SJ, Keller GM.
    Cold Spring Harb Symp Quant Biol; 2008; 73():101-10. PubMed ID: 19329573
    [Abstract] [Full Text] [Related]

  • 2. Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development.
    Murry CE, Keller G.
    Cell; 2008 Feb 22; 132(4):661-80. PubMed ID: 18295582
    [Abstract] [Full Text] [Related]

  • 3. Propensity of human embryonic stem cell lines during early stage of lineage specification controls their terminal differentiation into mature cell types.
    Pal R, Totey S, Mamidi MK, Bhat VS, Totey S.
    Exp Biol Med (Maywood); 2009 Oct 22; 234(10):1230-43. PubMed ID: 19546356
    [Abstract] [Full Text] [Related]

  • 4. Hepatic differentiation of pluripotent stem cells.
    Loya K, Eggenschwiler R, Ko K, Sgodda M, André F, Bleidissel M, Schöler HR, Cantz T.
    Biol Chem; 2009 Oct 22; 390(10):1047-55. PubMed ID: 19642877
    [Abstract] [Full Text] [Related]

  • 5. Cardiomyocytes from human pluripotent stem cells in regenerative medicine and drug discovery.
    Braam SR, Passier R, Mummery CL.
    Trends Pharmacol Sci; 2009 Oct 22; 30(10):536-45. PubMed ID: 19762090
    [Abstract] [Full Text] [Related]

  • 6. Derivation of human embryonic germ cells: an alternative source of pluripotent stem cells.
    Turnpenny L, Brickwood S, Spalluto CM, Piper K, Cameron IT, Wilson DI, Hanley NA.
    Stem Cells; 2003 Oct 22; 21(5):598-609. PubMed ID: 12968114
    [Abstract] [Full Text] [Related]

  • 7. Prospects for pluripotent stem cell-derived cardiomyocytes in cardiac cell therapy and as disease models.
    Freund C, Mummery CL.
    J Cell Biochem; 2009 Jul 01; 107(4):592-9. PubMed ID: 19449339
    [Abstract] [Full Text] [Related]

  • 8. Patterning definitive hematopoietic stem cells from embryonic stem cells.
    Lengerke C, Daley GQ.
    Exp Hematol; 2005 Sep 01; 33(9):971-9. PubMed ID: 16140144
    [Abstract] [Full Text] [Related]

  • 9. Epiblast stem cells contribute new insight into pluripotency and gastrulation.
    Chenoweth JG, McKay RD, Tesar PJ.
    Dev Growth Differ; 2010 Apr 01; 52(3):293-301. PubMed ID: 20298258
    [Abstract] [Full Text] [Related]

  • 10. Impacts of recent advances in cardiovascular regenerative medicine on clinical therapies and drug discovery.
    Murata M, Tohyama S, Fukuda K.
    Pharmacol Ther; 2010 May 01; 126(2):109-18. PubMed ID: 20156482
    [Abstract] [Full Text] [Related]

  • 11. Signaling pathways controlling second heart field development.
    Rochais F, Mesbah K, Kelly RG.
    Circ Res; 2009 Apr 24; 104(8):933-42. PubMed ID: 19390062
    [Abstract] [Full Text] [Related]

  • 12. Embryonic stem cell differentiation: emergence of a new era in biology and medicine.
    Keller G.
    Genes Dev; 2005 May 15; 19(10):1129-55. PubMed ID: 15905405
    [Abstract] [Full Text] [Related]

  • 13. Human embryonic stem cells: current technologies and emerging industrial applications.
    Améen C, Strehl R, Björquist P, Lindahl A, Hyllner J, Sartipy P.
    Crit Rev Oncol Hematol; 2008 Jan 15; 65(1):54-80. PubMed ID: 17689256
    [Abstract] [Full Text] [Related]

  • 14. Cardiomyocytes derived from human embryonic stem cells - characteristics and utility for drug discovery.
    Steel D, Hyllner J, Sartipy P.
    Curr Opin Drug Discov Devel; 2009 Jan 15; 12(1):133-40. PubMed ID: 19152222
    [Abstract] [Full Text] [Related]

  • 15. Differentiation of human embryonic stem cells after transplantation in immune-deficient mice.
    Przyborski SA.
    Stem Cells; 2005 Oct 15; 23(9):1242-50. PubMed ID: 16210408
    [Abstract] [Full Text] [Related]

  • 16. Human stem cells for modeling neurological disorders: accelerating the drug discovery pipeline.
    Crook JM, Kobayashi NR.
    J Cell Biochem; 2008 Dec 15; 105(6):1361-6. PubMed ID: 18980214
    [Abstract] [Full Text] [Related]

  • 17. Directed and systematic differentiation of cardiovascular cells from mouse induced pluripotent stem cells.
    Narazaki G, Uosaki H, Teranishi M, Okita K, Kim B, Matsuoka S, Yamanaka S, Yamashita JK.
    Circulation; 2008 Jul 29; 118(5):498-506. PubMed ID: 18625891
    [Abstract] [Full Text] [Related]

  • 18. Stem cells: current challenges and future promise.
    Battey JF.
    Dev Dyn; 2007 Dec 29; 236(12):3193-8. PubMed ID: 17584855
    [Abstract] [Full Text] [Related]

  • 19. Cardiomyocyte differentiation of human induced pluripotent stem cells.
    Zwi L, Caspi O, Arbel G, Huber I, Gepstein A, Park IH, Gepstein L.
    Circulation; 2009 Oct 13; 120(15):1513-23. PubMed ID: 19786631
    [Abstract] [Full Text] [Related]

  • 20. Modeling human hematopoietic cell development from pluripotent stem cells.
    Kardel MD, Eaves CJ.
    Exp Hematol; 2012 Aug 13; 40(8):601-11. PubMed ID: 22510344
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 46.